Options
| ShowHide Related Items >><< - 11/01/22
- Sirius XM continues to expect positive 2022 self-pay net subscriber additions
- 11/01/22
- Sirius XM reports Q3 self-pay subscribers 32.3M
- 11/01/22
- Sirius XM raises quarterly cash dividend 10%
- 10/31/22
- Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles
- 01/03/23 JPMorgan
- Sirius estimates cut on 'challenged' advertising market at JPMorgan
- 12/01/22 Citi
- Sirius XM downgraded to Sell from Buy at Citi
- 11/02/22 Deutsche Bank
- Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
- 11/02/22 Pivotal Research
- Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/01/22
- Sirius XM reports Q3 adjusted EPS 7c, consensus 8c
- 11/01/22
- Sirius XM sees FY22 revenue $9B, consensus $9.04B
- 11/01/22
- Sirius XM reports Q3 diluted EPS 6c, consensus 8c
- 12/01/22
- Sirius XM to cut staff amid faltering sales growth, Bloomberg reports
- 12/01/22
- Sirius XM to reduce staff in coming weeks, Bloomberg reports
- 08/31/22
- James Van Der Beek sues SiriusXM over podcast deal, THR reports
- 12/01/22
- What You Missed On Wall Street On Thursday
- 12/01/22
- What You Missed On Wall Street This Morning
- 11/28/22
- Fly Insider: Autoscope, Archer Aviation among week's notable insider trades
- 11/01/22
- Fly Intel: Pre-market Movers
- 01/05/23
- Largest borrow rate increases among liquid names
- 12/30/22
- Sirius XM call volume above normal and directionally bullish
- 12/22/22
- Sirius XM put volume heavy and directionally bearish
- 12/06/22
- Largest borrow rate increases among liquid names
|
Hot Stocks
| ShowHide Related Items >><< - 01/30/23
- Sony says consumers should now have an 'easier time' finding PS5s at retailers
- 01/27/23
- HBO renews 'The Last of Us' for a second season
- 01/24/23
- Sony Group trading resumes
- 01/24/23
- Sony Group trading halted, volatility trading pause
- 11/02/22 Cowen
- Sony price target lowered to $102 from $144 at Cowen
- 10/13/22 Oppenheimer
- Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
- 09/07/22 Goldman Sachs
- Sony resumed with a Neutral at Goldman Sachs
- 07/08/22 Macquarie
- Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
- 11/01/22
- Sony raises FY revenue view to Y11.6T from Y11.5T
- 11/01/22
- Sony reports Q2 revenue Y2.752T vs. Y2.369T last year
- 01/31/23
- Sony tells GI.biz it has not cut PSVR2 output numbers
- 01/31/23
- Sony halves Q1 PSVR2 headset shipment forecast, Bloomberg reports
- 01/30/23
- Xbox, PlayStation, Nintendo to skip E3 2023, IGN reports
- 01/30/23
- EA's 'Dead Space' top-selling physical game in U.K., GI.biz says
- 01/31/23
- What You Missed This Week in Video Games
- 01/29/23
- Box Office Battle: ‘Avatar 2’ stays atop chart in seventh weekend
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/25/23
- #SocialStocks: Musk refutes veracity of WSJ story that he seeks $3B in funding
- 09/30/22
- Largest borrow rate increases among liquid names
|
Hot Stocks
| ShowHide Related Items >><< - 01/19/23
- Fifth Third sees Q1 total revenue down 4%-5% vs. 4Q22, consensus $2.29B
- 01/19/23
- Fifth Third sees FY23 total revenue up 9%-10% vs. FY22, consensus $9.34B
- 12/14/22
- Fifth Third to increase prime lending rate to 7.50%
- 11/02/22
- Fifth Third to increase prime lending rate to 7%
- 01/06/23 Deutsche Bank
- Fifth Third price target lowered to $37 from $44 at Deutsche Bank
- 01/05/23 BofA
- BofA downgrades PNC Financial to Underperform, says EPS defensibility priced in
- 01/03/23 Barclays
- Fifth Third price target lowered to $47 from $48 at Barclays
- 12/21/22 DA Davidson
- Fifth Third initiated with a Neutral at DA Davidson amid 'well deserved premium'
- 01/19/23
- Fifth Third reports Q4 EPS $1.01, consensus $1.00
- 01/18/23
- Notable companies reporting before tomorrow's open
- 01/18/23
- Notable companies reporting before tomorrow's open
- 10/20/22
- Fifth Third reports Q3 EPS 91c, consensus 98c
- 10/08/22
- Bank stocks have gotten slammed, M&T among those worth a look, Barron's says
- 12/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/20/22
- Fly Intel: Pre-market Movers
- 01/18/23
- Largest borrow rate increases among liquid names
- 10/24/22
- Early notable gainers among liquid option names on October 24th
|
Downgrade
| ShowHide Related Items >><< - 01/17/23
- Cellectis announces Calyxt, Cibus sign definitive merger agreement
- 01/17/23
- Calyxt, Cibus enter definitive all-stock merger agreement
- 11/18/22
- Calyxt reports completing first phase in palm oil research collaboration pact
- 11/17/22
- Calyxt granted 180-day extension by Nasdaq to regain compliance
- 11/04/22 H.C. Wainwright
- Calyxt downgraded to Neutral from Buy at H.C. Wainwright
- 03/04/22 Canaccord
- Calyxt price target lowered to $4.00 from $6.00 at Canaccord
- 11/03/22
- Calyxt reports Q3 adjusted EPS (13c), consensus (14c)
- 08/04/22
- Calyxt reports Q2 EPS (5c) vs. (13c) a year ago
|
Options
| ShowHide Related Items >><< - $100.51 /
+0.275 (+0.27%) - 01/03/23
- C.H. Robinson CEO Bob Biesterfeld steps down, Scott Anderson named interim CEO
- 11/17/22
- C.H. Robinson raises quarterly dividend to 61c per share from 55c
- 11/02/22
- C.H. Robinson sees $175M of gross cost savings in Q4
- $100.51 /
+0.275 (+0.27%) - 01/17/23 BofA
- Schneider, Werner upgraded to Buy, XPO Logistics downgraded at BofA
- 01/17/23 BofA
- C.H. Robinson downgraded to Underperform from Neutral at BofA
- 01/11/23 JPMorgan
- C.H. Robinson downgraded to Neutral from Overweight at JPMorgan
- 01/11/23 KeyBanc
- C.H. Robinson price target lowered to $110 from $120 at KeyBanc
- $100.51 /
+0.275 (+0.27%) - 13:48 Today
- Notable companies reporting after market close
- 11/02/22
- C.H. Robinson reports Q3 EPS $1.78, consensus $2.17
- $100.51 /
+0.275 (+0.27%) - 01/10/23
- C.H. Robinson reaches standstill agreement with Ancora, WSJ reports
- $100.51 /
+0.275 (+0.27%) - 01/11/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/15/22
- Fly Intel: After-Hours Movers
|
General news
|
The Federal Reserve said… The Federal Reserve said in today's statement, "The Committee seeks to achieve maximum employment and inflation at the rate of 2 percent over the longer run. In support of these goals, the Committee decided to raise the target range for the federal funds rate to 4-1/2 to 4-3/4 percent. The Committee anticipates that ongoing increases in the target range will be appropriate in order to attain a stance of monetary policy that is sufficiently restrictive to return inflation to 2 percent over time. In determining the extent of future increases in the target range, the Committee will take into account the cumulative tightening of monetary policy, the lags with which monetary policy affects economic activity and inflation, and economic and financial developments. In addition, the Committee will continue reducing its holdings of Treasury securities and agency debt and agency mortgage-backed securities, as described in its previously announced plans. The Committee is strongly committed to returning inflation to its 2 percent objective." ShowHide Related Items >><< - 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
SPY SPDR S&P 500 ETF Trust - $404.44 /
-2.015 (-0.50%) - 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
SPY SPDR S&P 500 ETF Trust - $404.44 /
-2.015 (-0.50%) - 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
- 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
SPY SPDR S&P 500 ETF Trust - $404.44 /
-2.015 (-0.50%) - 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
SPY SPDR S&P 500 ETF Trust - $404.44 /
-2.015 (-0.50%) - 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 09/23/22
- SPX Option volume on track for 3.25m contracts, 2nd highest on record
SPY SPDR S&P 500 ETF Trust - $404.44 /
-2.015 (-0.50%) - 08:24 Today
- SPDR S&P 500 ETF Trust: Pivot points
- 01/31/23
- SPDR S&P 500 ETF Trust: Pivot points
- 01/30/23
- SPDR S&P 500 ETF Trust: Pivot points
- 01/27/23
- SPDR S&P 500 ETF Trust: Pivot points
|
General news
| ShowHide Related Items >><< - 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
SPY SPDR S&P 500 ETF Trust - 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
SPY SPDR S&P 500 ETF Trust - 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
- 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
SPY SPDR S&P 500 ETF Trust - 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 01/22/23
- Fed sets course for milder interest-rate rise next month, WSJ says
- 11/04/22
- Fed's Evans says smaller rate hikes make sense, Reuters reports
- 10/22/22
- Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
SPY SPDR S&P 500 ETF Trust - 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 09/23/22
- SPX Option volume on track for 3.25m contracts, 2nd highest on record
SPY SPDR S&P 500 ETF Trust - 08:24 Today
- SPDR S&P 500 ETF Trust: Pivot points
- 01/31/23
- SPDR S&P 500 ETF Trust: Pivot points
- 01/30/23
- SPDR S&P 500 ETF Trust: Pivot points
- 01/27/23
- SPDR S&P 500 ETF Trust: Pivot points
|
Options
| ShowHide Related Items >><< - 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 12/02/22
- Urban Outfitters Group president Francis Pierrel departs
- 08/23/22
- Urban Outfitters sees Q3 sales up low single digits, gross margins down 400bps
- 08/23/22
- Urban Outfitters says 19.2M shares remain available for buyback
- 01/13/23 Barclays
- Urban Outfitters price target raised to $27 from $26 at Barclays
- 01/11/23 Deutsche Bank
- Urban Outfitters price target raised to $25 from $22 at Deutsche Bank
- 11/23/22 Barclays
- Urban Outfitters price target raised to $26 from $19 at Barclays
- 11/22/22 BMO Capital
- Urban Outfitters price target raised to $24 from $19 at BMO Capital
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 08/23/22
- Urban Outfitters reports Q2 EPS 64c vs. $1.28 last year
- 08/23/22
- Notable companies reporting after market close
- 11/22/22
- What You Missed On Wall Street On Tuesday
- 11/22/22
- What You Missed On Wall Street This Morning
- 08/24/22
- What You Missed On Wall Street On Wednesday
- 08/24/22
- What You Missed On Wall Street This Morning
- 01/05/23
- Urban Outfitters put volume heavy and directionally bearish
- 11/21/22
- Urban Outfitters options imply 7.9% move in share price post-earnings
- 08/23/22
- Urban Outfitters options imply 9.6% move in share price post-earnings
- 08/04/22
- Urban Outfitters call buyer realizes 41% same-day gains
|
Conference/Events
| |
Earnings
|
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c. ShowHide Related Items >><< - 01/27/23
- Eli Lilly says FDA approves Jaypirca
- 01/24/23
- Eli Lilly trading resumes
- 01/24/23
- Eli Lilly trading halted, volatility trading pause
- 01/24/23
- Eli Lilly to invest $450M to expand manufacturing at Research Triangle Park
- 01/27/23
- Merck's Keytruda approved by FDA for non-small cell lung cancer treatment
- 01/26/23
- Merck Animal Health announces FDA approval for Bravecto Chews for Dogs
- 01/25/23
- Merck to stop Phase 3 KEYNOTE-991 trial
- 01/25/23
- Merck reports 'positive' results from Phase 3 KEYNOTE-966 trial
- 01/31/23
- Prothena reports 'positive' topline Phase 1 study results for PRX005
- 01/27/23
- Bristol-Myers announces CHMP opinion recommending approval for Reblozyl
- 01/27/23
- Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP
- 01/26/23
- iVexSol closes $23.8M Series A-3 financing
- 12/19/22
- Honeywell confirms resolutions with DOJ, SEC, Brazil for $203M
- 12/19/22
- Honeywell pays $160M to resolve bribery investigations in U.S., Brazil
- 12/19/22
- Honeywell pays $81M to settle SEC Foreign Corrupt Practices charges
- 12/16/22
- Verra Mobility names Jon Keyser as Chief Legal Officer
- 11/15/22
- Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder
- 11/15/22
- Estee Lauder to acquire TOM FORD brand
- 11/02/22
- Estee Lauder raises quarterly dividend 10% to 66c from 60c per share
- 11/01/22
- Mondelez announces three new members to senior management team
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 08/31/22
- Hershey names Marlene Creighton as Global Chief Sales Officer
- 11/01/22
- Sirius XM continues to expect positive 2022 self-pay net subscriber additions
- 11/01/22
- Sirius XM reports Q3 self-pay subscribers 32.3M
- 11/01/22
- Sirius XM raises quarterly cash dividend 10%
- 10/31/22
- Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 09/15/22
- PayrHealth announces collaboration with Cardinal Health
- 01/23/23
- Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test
- 12/08/22
- Quest Diagnostics partners with Northern Light Health in Maine
- 12/01/22
- Quest Diagnostics awarded group purchasing agreement by Premier
- 11/28/22
- Quest Diagnostics completes acquisition of LabCare
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 12/29/22
- Nevada reports November statewide gaming win down 7.62% to $1.22B
- 12/20/22
- New Jersey reports November gaming revenue up 0.3% to $441.1M
- 12/08/22
- Penn Entertainment announces $750M share buyback program
- 01/20/23 William Blair
- Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair
- 01/12/23 Guggenheim
- Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
- 01/03/23 Barclays
- Eli Lilly price target raised to $400 from $395 at Barclays
- 12/23/22 Raymond James
- ProQR Therapeutics price target raised to $5 from $2 at Raymond James
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/04/23 BofA
- Merck upgraded to Buy at BofA on consistent revenue upside
- 01/04/23 BofA
- Merck upgraded to Buy from Neutral at BofA
- 01/03/23 Wells Fargo
- Merck price target raised to $125 from $110 at Wells Fargo
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/17/23 Cantor Fitzgerald
- Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
- 12/23/22 William Blair
- NccRCC 'material expansion opportunity' for Exelixis, says William Blair
- 11/17/22 Credit Suisse
- Bristol-Myers initiated with a Neutral at Credit Suisse
- 01/04/23 UBS
- Honeywell downgraded to Sell from Buy at UBS
- 12/09/22 Citi
- Honeywell price target raised to $248 from $213 at Citi
- 12/05/22 Deutsche Bank
- Honeywell price target raised to $242 from $227 at Deutsche Bank
- 12/01/22 Barclays
- Honeywell price target raised to $229 from $212 at Barclays
- 01/31/23 Jefferies
- Bath & Body Works price target raised to $52 from $45 at Jefferies
- 01/24/23 Stifel
- Estee Lauder price target raised to $295 from $255 at Stifel
- 01/23/23 Deutsche Bank
- Estee Lauder price target raised to $290 from $266 at Deutsche Bank
- 01/17/23 Oppenheimer
- Estee Lauder price target raised to $300 from $245 at Oppenheimer
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 01/03/23 Wells Fargo
- Hershey initiated with an Underweight at Wells Fargo
- 12/20/22 Morgan Stanley
- Hershey price target raised to $231 from $224 at Morgan Stanley
- 12/08/22 UBS
- Hershey upgraded to Buy from Neutral at UBS
- 01/03/23 JPMorgan
- Sirius estimates cut on 'challenged' advertising market at JPMorgan
- 12/01/22 Citi
- Sirius XM downgraded to Sell from Buy at Citi
- 11/02/22 Deutsche Bank
- Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
- 11/02/22 Pivotal Research
- Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 11/22/22 Credit Suisse
- Cardinal Health price target raised to $79 from $64 at Credit Suisse
- 11/14/22 Mizuho
- Cardinal Health price target raised to $74 from $66 at Mizuho
- 11/07/22 Baird
- Cardinal Health price target raised to $82 from $74 at Baird
- 01/23/23 Evercore ISI
- Quest Diagnostics initiated with an In Line at Evercore ISI
- 01/12/23 Baird
- Quest Diagnostics price target raised to $154 from $143 at Baird
- 12/14/22 Mizuho
- Quest Diagnostics price target raised to $165 from $160 at Mizuho
- 11/17/22 Citi
- Quest Diagnostics downgraded to Sell from Neutral at Citi
- 01/20/23 JMP Securities
- Penn Entertainment price target lowered to $45 from $48 at JMP Securities
- 01/11/23 Truist
- Penn Entertainment price target lowered to $36 from $40 at Truist
- 01/09/23 Jefferies
- Penn Entertainment downgraded to Hold at Jefferies as focus narrows
- 01/09/23 Jefferies
- Penn Entertainment downgraded to Hold from Buy at Jefferies
- 12/13/22
- Eli Lilly sees FY23 EPS $8.10-$8.30, consensus $9.15
- 12/13/22
- Eli Lilly backs FY22 EPS view $7.70-$7.85, consensus $7.78
- 11/01/22
- Eli Lilly cuts FY22 EPS view to $7.70-$7.85 from $7.90-$8.05, consensus $7.99
- 11/01/22
- Eli Lilly reports Q3 EPS $1.98, consensus $1.96
- 10/27/22
- Merck raises FY22 adjusted EPS view to $7.32-$7.37 from $7.25-$7.35
- 10/27/22
- Merck reports Q3 adjusted EPS $1.85, consensus $1.71
- 10/26/22
- Notable companies reporting before tomorrow's open
- 10/26/22
- Notable companies reporting before tomorrow's open
- 10/25/22
- Notable companies reporting before tomorrow's open
- 10/25/22
- Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51
- 10/25/22
- Bristol-Myers reports Q3 EPS $1.99, consensus $1.83
- 10/25/22
- Notable companies reporting before tomorrow's open
- 11/18/22
- Honeywell reaffirms Q4, 2022 guidance after asbestos settlement
- 10/27/22
- Honeywell sees Q4 adjusted EPS $2.46-$2.56, consensus $2.51
- 10/27/22
- Honeywell narrows FY22 adjusted EPS view to $8.70-$8.80 from $8.55-$8.80
- 10/27/22
- Honeywell reports Q3 adjusted EPS $2.25, consensus $2.16
- 11/02/22
- Estee Lauder cuts FY23 adjusted EPS view to $5.25-$5.40. from $7.39-7.54
- 11/02/22
- Estee Lauder sees Q2 adjusted EPS $1.19-$1.29, consensus $2.81
- 11/02/22
- Estee Lauder reports Q1 EPS $1.37, consensus $1.31
- 11/01/22
- Notable companies reporting before tomorrow's open
- 11/04/22
- Hershey raises FY22 adjusted EPS view to $8.20-$8.27 from $8.05-$8.20
- 11/04/22
- Hershey reports Q3 adjusted EPS $2.17, consensus $2.10
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/01/22
- Sirius XM reports Q3 adjusted EPS 7c, consensus 8c
- 11/01/22
- Sirius XM sees FY22 revenue $9B, consensus $9.04B
- 11/01/22
- Sirius XM reports Q3 diluted EPS 6c, consensus 8c
- 10/31/22
- Notable companies reporting before tomorrow's open
- 11/04/22
- Cardinal Health backs FY23 EPS view $5.05-$5.40, consensus $5.24
- 11/04/22
- Cardinal Health reports Q1 EPS $1.20, consensus 94c
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Notable companies reporting before tomorrow's open
- 10/20/22
- Quest Diagnostics raises FY22 adjusted EPS view to $9.75-$9.95 from $9.55-$9.95
- 10/20/22
- Quest Diagnostics reports Q3 adjusted EPS $2.36, consensus $2.19
- 11/03/22
- Penn Entertainment reports Q3 EPS 72c, consensus 38c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Penn National reports Q2 EPS 15cvs $1.17 last year
- 12/19/22
- Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 10/11/22
- New quality issues found at Eli Lilly drug plant, Reuters reports
- 08/13/22
- Eli Lilly, Novo Nordisk weight-loss drugs could be blockbusters, Barron's says
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/11/23
- Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says
- 12/30/22
- Merck's Covid treatment gets conditional approval in China, Reuters reports
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 01/04/23
- Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 09/19/22
- Defense companies urged to limit use of Chinese supplies, WSJ reports
- 11/16/22
- Zegna to acquire rest of Tom Ford International, Bloomberg reports
- 11/15/22
- Estee Lauder to acquire Tom Ford in deal valued at $2.8B, WSJ reports
- 11/15/22
- Estee Lauder nearing deal to acquire Tom Ford for $2.8B, WSJ reports
- 11/11/22
- Estee Lauder near deal to acquire Tom Ford for $2.8B, FT reports
- 12/30/22
- Hershey sued over metals content in dark chocolate, Reuters says
- 12/19/22
- Hershey among brands called out by Consumer Reports for lead exposure
- 12/01/22
- Sirius XM to cut staff amid faltering sales growth, Bloomberg reports
- 12/01/22
- Sirius XM to reduce staff in coming weeks, Bloomberg reports
- 08/31/22
- James Van Der Beek sues SiriusXM over podcast deal, THR reports
- 09/22/22
- Activist Elliott would like to see Pinterest put up for sale, Barron's says
- 08/15/22
- Elliott has large stake in Cardinal Health, seeks board seats, WSJ says
- 12/19/22
- Doctors gain confidence in new Alzheimer's blood tests, Bloomberg reports
- 01/23/23
- Biotech Alert: Searches spiking for these stocks today
- 01/20/23
- What You Missed On Wall Street This Morning
- 01/20/23
- Fly Intel: Pre-market Movers
- 12/19/22
- What You Missed On Wall Street On Monday
- 01/12/23
- Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover
- 01/04/23
- What You Missed On Wall Street This Morning
- 01/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Biotech Alert: Searches spiking for these stocks today
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/10/22
- Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo
- 01/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/19/22
- What You Missed On Wall Street On Monday
- 11/18/22
- What You Missed On Wall Street On Friday
- 10/27/22
- What You Missed On Wall Street On Thursday
- 12/17/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/10/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/07/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/08/22
- What You Missed On Wall Street On Thursday
- 12/08/22
- What You Missed On Wall Street This Morning
- 12/01/22
- What You Missed On Wall Street On Thursday
- 12/01/22
- What You Missed On Wall Street This Morning
- 11/28/22
- Fly Insider: Autoscope, Archer Aviation among week's notable insider trades
- 11/01/22
- Fly Intel: Pre-market Movers
- 11/04/22
- Fly Intel: Pre-market Movers
- 09/28/22
- #SocialStocks: Details of Musk's deposition by Twitter still being hammered out
- 08/15/22
- What You Missed On Wall Street On Monday
- 08/11/22
- Fly Intel: Pre-market Movers
- 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/19/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/20/22
- Fly Intel: Pre-market Movers
- 01/20/23
- Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization
- 01/13/23
- Bet On It: PlayUp SPAC deal terminated
- 01/09/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/06/23
- Bet On It: Three downstate New York casino licenses now up for grabs
- 11/01/22
- Unusually active option classes on open November 1st
- 10/03/22
- Eli Lilly And Co put volume heavy and directionally bearish
- 09/28/22
- Early notable gainers among liquid option names on September 28th
- 09/28/22
- Unusually active option classes on open September 28th
- 01/10/23
- Largest borrow rate increases among liquid names
- 12/07/22
- Largest borrow rate increases among liquid names
- 11/14/22
- Early notable gainers among liquid option names on November 14th
- 10/10/22
- Early notable gainers among liquid option names on October 10th
- 09/29/22
- Early notable gainers among liquid option names on September 29th
- 09/12/22
- Early notable gainers among liquid option names on September 12th
- 09/12/22
- Unusually active option classes on open September 12th
- 09/08/22
- Notable open interest changes for September 8th
- 01/18/23
- Honeywell put volume heavy and directionally bearish
- 12/21/22
- Early notable gainers among liquid option names on December 21st
- 11/04/22
- Early notable gainers among liquid option names on November 4th
- 11/16/22
- Early notable gainers among liquid option names on November 16th
- 01/05/23
- Largest borrow rate increases among liquid names
- 12/30/22
- Sirius XM call volume above normal and directionally bullish
- 12/22/22
- Sirius XM put volume heavy and directionally bearish
- 12/06/22
- Largest borrow rate increases among liquid names
- 12/02/22
- Early notable gainers among liquid option names on December 2nd
- 11/11/22
- Cardinal Health put volume heavy and directionally bearish
- 10/10/22
- Cardinal Health call volume above normal and directionally bullish
- 08/12/22
- Early notable gainers among liquid option names on August 12th
- 12/14/22
- Penn National call volume above normal and directionally bullish
- 12/09/22
- Unusually active option classes on open December 9th
- 12/08/22
- Penn National put volume heavy and directionally bearish
- 11/14/22
- Penn National call volume above normal and directionally bullish
|